Abstract
In this study, the central technique of in vitro culture has been used to further investigate whether LH/FSH-expressing, but clinically
“functionless” pituitary adenomas are gonadotropinomas or whether their hormone secretion
is due to transdifferentiation events. 664 “functionless” pituitary adenomas were
examined for hormone secretion by in vitro culture and for hormone content by immunostaining. The results were correlated with
the clinical findings. 40 % of the tumours (n = 263) secreted at least one of the
gonadotropins alone, 8 % (n = 53) exhibited various patterns of anterior pituitary
hormones, whilst the remaining 52 % of tumours were not associated with any hormone.
In the secretory tumours, immunostaining revealed only a few scattered hormone-containing
cells (5 to 15 %). Mild hyperprolactinaemia was observed in some cases, presumably
because of pressure effects of the tumours. The majority of the patients suffered
clear cut hypopituitarism (p < 0.05). Pre-operatively, gonadotropin hypersecretion
was observed in 3 cases, but only one of these secreted hormones in culture. Interestingly,
a higher proportion of tumours removed from patients with hypopituitarism showed secretory
activity in vitro than those tumours removed from patients showing no hormonal dysfunction or hyperprolactinaemia.
We conclude that the term “gonadotropinoma” to describe functionless pituitary tumours
associated with LH and/or FSH secretion is a misnomer, because the presence of LH
and/or FSH confirmed by in vitro methods in the present series is a result of only a few scattered cells. We suggest
that primary pituitary tumour cells differentiate into a secretory type (transdifferentiation),
possibly in response to altered serum hormone levels such as decreased steroids. Further
work is required to identify the factors which trigger the altered cells' characteristics.
Key words
Pituitary adenoma - hypopituitarism -
in vitro
- gonadotrophinoma transdifferentiation
References
1
Adams E F, Mashiter K.
Role of cell and explant culture in the diagnosis and characterization of human pituitary
tumours.
Neurosurg Rev.
1985;
8
135-140
2
Al-Gahtany M, Horvath E, Kovacs K.
Pituitary hyperplasia.
Hormones.
2003;
2
149-158
3
Black P, Hsu D W, Klibanski A, Kliman B, Jameson L, Ridgway C, Hedley-Whyte E T, Zervas N T.
Hormone production in clinically non-functioning pituitary adenomas.
J Neurosurg.
1987;
66
244-250
4
Chaidarun S S, Klibanski A.
Gonadotropinomas.
Semin Reprod Med.
2002;
20
339-348
5
Childs G V.
Development of gonadotropes may involve cyclic transdifferentiation of growth hormone
cells.
Arch Physiol Biochem.
2002;
110
42-49
6
Croue A, Beldent V, Rousselet M C, Guy G, Rohmer V, Bigorgne J C, Saint-Andre J P.
Contribution of immunohistochemistry, electron microscopy, and cell culture to the
characterization of nonfunctioning pituitary adenomas: a study of 40 cases.
Hum Pathol.
1992;
23
1332-1339
7
Fahlbusch R, Schrell U, Buchfelder M.
Neurochirurgische Behandlung von Adenomen der Hypophyse.
Nervenheilkunde.
1985;
62
1556-1560
8
Hardy J.
Transsphenoidal microsurgery of the normal and pathological pituitary.
Clin Neurosurg.
1979;
16
185-217
9
Hsu S M, Raine L, Ranger H.
A comparative study of peroxidase-antiperoxidades method and an avidin-biotin complex
method for studying polypeptide hormones with radioummunoassay antibodies.
Am J Clin Pathol.
1981;
75
734-738
10
Kakeya T, Takeuchi S, Takahashi S.
Epidermal growth factor, insulin and estrogen stimulate development of prolactin-secreting
cells in culture of GH3 cells.
Cell Tissue Res.
2000;
299
237-243
11
Kakeya T, Takeuchi S, Takahashi S.
Introduction of mammotroph development by a combination of epidermal growth factor,
insulin and estradiol-17β in rat pituitary tumor GH3 cells.
Zoolog Sci.
2002;
19
789-795
12
Kineman R D, Faught W J, Fawley S.
Steroids can modulate transdifferentiation of prolactin and growth hormone cells in
bovine pituitary cultures.
Endocrinol.
1992;
130
3289-3294
13
Kovacs K, Horvath E, Van Loon G R, Rewcastle N B, Ezrin C, Rosenbloom A A.
Pituitary adenomas associated with elevated blood follicle-stimulating hormone levels:
a histologic, immunocytologic and electron microscopic study of two cases.
Fertil Steril.
1978;
29
622-628
14
Kovacs K, Horvath E, Vidal S.
Classification of pituitary adenomas.
J Neuro Oncol.
2001;
54
121-127
15
Levis P D, Van Noorden S.
Nonfunctioning pituitary tumours: a light and electron microscopical study.
Arch Pathol.
1974;
97
178-182
16
Losa M, Mortini P, Barzaghi R, Franzin A, Giovanelli M.
Endocrine inactive and gonadotroph adenomas: diagnosis and management.
J Neuro Oncol.
2001;
54
167-177
17
Mashiter K, Adams E F, Gillies G, Van Noorden S, Ratter S.
Adrenocorticotropin and lipotropin secretion by dispersed cell cultures of a human
corticotropic adenoma: effect of hypothalamic extract arginine, vasopressin, hydrocortisone
and serotonin.
J Clin Endocrinol Metab.
1980;
51
566-572
18
Mashiter K, Adams E F, Van Noorden S.
Secretion of LH, FSH and PRL shown by cell culture and immunohistochemistry of human
functionless pituitary adenomas.
Clin Endocrinol.
1981;
15
103-112
19
Mashiter K, Van Noorden S, De Marco L, Adams E, Joplin G F.
Hormone secretion by human somatotrophic and mixed pituitary adenomas in culture.
J Clin Endocrinol Metab.
1979;
48
108-113
20
Miura M, Matsukado Y, Kodama T, Mihasa Y.
Clinical and histopathological characteristics of gonadotropin-producing pituitary
adenomas.
J Neurosurg.
1985;
62
376-382
21
Petersen B, Buchfelder M, Fahlbusch R, Adams E F.
Pituitary adenylate cyclase activating polypeptide directly stimulates LH and FSH
secretion by human pituitary gonadotrophinomas.
Exp Clin Endocrinol Diabetes.
1996;
104
250-255
22
Saeger W.
Hypophysentumoren.
Pathologe.
2003;
24
255-264
23
Sano N, Teramoto A, Osamura Y, Horvath E, Kovacs K, Lloyd R, Scheithauer B W.
Pathology of pituitary tumors.
Neurosurg Clin N Am.
2003;
14
25-39
24
Schmid M, Münscher A, Saeger W, Schreiber S, Lüdecke D K.
Pituitary hormone mRNA in null cell adenomas and oncocytomas by in situ hybridisation.
Comparison with immunohistochemical and clinical data.
Pathol Res Pract.
2001;
197
663-669
25
Snyder P J, Bashey H M, Phillips J L, Genarelli T A.
Comparison of hormonal secretory behaviour of gonadotroph cell adenoma in vitro and in culture.
J Clin Endocrinol Metab.
1985;
61
1061-1065
26
Surmont D WA, Winslow C JL, Loizou M, White M C, Adams E F, Mashiter K.
Gonadotrophin and alpha subunit secretion by human functionless pituitary adenomas
in cell culture: long term effects of luteinizing hormone releasing hormone and thyreotrophin
releasing hormone.
Clin Endocrinol.
1983;
19
325-336
27
Symon L, Jahnbowski J, Kendall B.
Surgical treatment of giant pituitary adenomas.
J Neurol Neurosurg Psych.
1979;
42
973-982
28
Trouillas J, Girod C, Sassolas G, Claustrat B.
The human gonadotropic adenoma: pathologic diagnosis and hormonal correlations in
26 tumours.
Semin Diagn Pathol.
1986;
3
42-57
29
Vidal S, Horvath E, Kovacs K, Cohen S M, Lloyd R V, Scheithauer B W.
Transdifferentiation of somatotrophs to thyreotrophs in the pituitary of patients
with proctated primary hypothyreodism.
Virchows Arch.
2000;
436
43-51
30
Vidal S, Horvath E, Kovacs K, Lloyd R V, Smyth H S.
Reversible transdifferentiation: interconversion of somatotrophs and lactotrophs in
pituitary hyperplasia.
Mod Pathol.
2001;
14
20-28
31
Zhao D, Tomono Y, Tsuboi K, Nose T.
Immunohistochemical and ultrastructural study of clinically nonfunctioning pituitary
adenomas.
Neurol Med Chir (Tokyo).
2000;
40
453-456
Prof. Dr. med. M. Buchfelder
Department of Neurosurgery, University of Göttingen
Robert-Koch-Straße 40
37075 Göttingen
Germany
Telefon: + 49551396033
Fax: + 49 5 51 39 87 94
eMail: buchfelder@med.uni-goettingen.de